Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1981 Nov 1;154(5):1671-80.
doi: 10.1084/jem.154.5.1671.

Deficient interleukin 2 activity in MRL/Mp and C57BL/6J mice bearing the lpr gene

Deficient interleukin 2 activity in MRL/Mp and C57BL/6J mice bearing the lpr gene

D Wofsy et al. J Exp Med. .

Abstract

Spleen cells from MRL-lpr and B6-lpr mice have a marked defect in the ability to produce interleukin 2 (IL-2) in response to concanavalin A stimulation. This defect precedes the onset of clinical illness, increases with age, and eventually becomes virtually absolute. It is not due to cellular suppression of IL-2 production, nor does it reflect the presence of a soluble inhibitor of IL-2 activity. Failure to restore IL-2 production with macrophage-replacing factors, such as interleukin 1 and phorbol myristic acetate, suggests that IL-2 deficiency reflects a primary T cell defect rather than a macrophage defect. MRL-lpr and B6-lpr spleen cells also have an age-dependent reduction in IL-2 response that apparently results from a deficiency of cell surface receptors for IL-2. Congenic MRL-+/+ and B6-+/+ mice, which lack the lpr gene responsible for accelerated autoimmunity and lymphoproliferation, have normal IL-2 activity. These findings suggest that a defect in IL-2 activity may contribute to impaired immunoregulation in mice bearing the lpr gene. The absence of such a defect in MRL-+/+ and B6-+/+ mice further suggests that a single autosomal recessive gene is responsible for IL-2 deficiency.

PubMed Disclaimer

References

    1. Proc Natl Acad Sci U S A. 1980 Oct;77(10):6134-8 - PubMed
    1. Immunopharmacology. 1980 Jun;2(3):233-45 - PubMed
    1. J Immunol. 1978 Jun;120(6):1974-80 - PubMed
    1. J Immunol. 1978 Jun;120(6):2027-32 - PubMed
    1. J Immunol. 1978 Oct;121(4):1353-60 - PubMed

Publication types